mounjaro is a semaglutide vs Ozempic Expert Endocrinologist Explains the Difference Semaglutide vs Mounjaro: Key Differences

The company plans to submit for a type 2 diabetes indication in 2026 as well, with potential approval for that indication in 2027

People lose on average about 14 percent of their body weight on semaglutide, about 20 percent on tirzepatide, and about 28 percent on retatrutide

However, careful monitoring is required, particularly for gastrointestinal adverse effects that may complicate autoimmune disease management, and multidisciplinary collaboration is advisable

hsCRP, high sensitivity C reactive protein

Further, DNA was extracted from 100 ul of buffycoat by using a QIAamp (R) DNA minikit (Qiagen, Switzerland) by following the instruction manual